ArticleJournal of virus eradication2019

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study.

Sofie Rutsaert et al.PubMed ↗Full text ↗

No numbers read from the abstract.